Gallant in the News

TechCrunch Spotlights Gallant’s Breakthrough Approach to Pet Stem Cell

dvm360 Reports on Gallant’s Platform and Path Toward FDA-Labeled Therapies

BioProcess Insider Covers Gallant’s $18M Raise and Manufacturing Expansion

PetVet Magazine Publishes Feature by Dr. Linda Black on the Rise of Ready-to-Use Stem Cell Therapies

Veterinary Practice’s Innovation Feature for February 2024 Covers FCGS Study

dvm360 Covers Aaron Schacht’s Appointment to Gallant Board

Gallant is redefining veterinary medicine with ready-to-use stem cell therapies that reduce inflammation, restore function, and fit seamlessly into everyday practice.

Gallant in the News

Stay Curious